-
Mashup Score: 3
Zach Klaassen hosts a discussion with Connor O’Leary and Freeman McClusky, both testicular cancer survivors. They delve into the history and mission of Testicular Cancer Foundation (TCF), emphasizing its focus on education, awareness, and support since its inception in 2009. The conversation highlights the importance of community and brotherhood among survivors, with TCF playing a pivotal role…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 7Cancer of the Testis - Cancer Stat Facts - 4 day(s) ago
Testicular Cancer statistics
Source: seer.cancer.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Testicular Cancer, Information, Resources, Support - 8 day(s) ago
Information and resources about testicular cancer from CancerCare.
Source: www.cancercare.orgCategories: General Medicine News, NursingTweet
-
Mashup Score: 15
ed therapy, including surgical interventions, chemotherapy regimens, and radiation therapy. The effectiveness of these treatments varies depending on the site of metastasis, with various approaches improving survival rates and quality of life for patients. We divide our review in an organ-specific manner and focus on chemotherapeutic, surgical, and radiation therapy approaches pertaining to each site of metastasis. Summary Our review suggests the pressing need for continued research to refine and personalize treatment strategies. These efforts are important for enhancing clinical practice, ultimately leading to better outcomes for patients with metastatic testicular cancer….
Source: journals.lww.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Cancer of the Testis - Cancer Stat Facts - 11 day(s) ago
Testicular Cancer statistics
Source: seer.cancer.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Testicular Cancer Survivors Find Community and Healing Through Foundation and Patient Summit - Connor O'Leary & Charles Freeman McCluskey - 23 day(s) ago
Zach Klaassen hosts a discussion with Connor O’Leary and Freeman McClusky, both testicular cancer survivors. They delve into the history and mission of Testicular Cancer Foundation (TCF), emphasizing its focus on education, awareness, and support since its inception in 2009. The conversation highlights the importance of community and brotherhood among survivors, with TCF playing a pivotal role…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 3Testicular Cancer Survivors Find Community and Healing Through Foundation and Patient Summit - Connor O'Leary & Charles Freeman McCluskey - 2 month(s) ago
Zach Klaassen hosts a discussion with Connor O’Leary and Freeman McClusky, both testicular cancer survivors. They delve into the history and mission of Testicular Cancer Foundation (TCF), emphasizing its focus on education, awareness, and support since its inception in 2009. The conversation highlights the importance of community and brotherhood among survivors, with TCF playing a pivotal role…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 7Cancer of the Testis - Cancer Stat Facts - 2 month(s) ago
Testicular Cancer statistics
Source: seer.cancer.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer - 3 month(s) ago
PURPOSE Systemic chemotherapy, depending on the regimen, can be administered through peripheral intravenous (pIV) access or through central venous access devices (CVADs). There is no current best practice regarding optimal access for chemotherapy for patients with testicular cancer (TC). We retrospectively evaluated patients undergoing systemic chemotherapy for TC and compared baseline characteristics and complications of patients using pIV versus CVADs. METHODS We included patients with TC who underwent first-line systemic chemotherapy at the University of Colorado Hospitals from 2005 to 2020. Data were collected on demographics, cancer characteristics, type, duration of chemotherapy, pIV or CVAD use, and associated complication rates. We then performed univariate and multivariate regression analyses to compare complication rates and risk factors for each group. RESULTS One hundred fifty-four patients met inclusion criteria. Ninety-two (60%) patients used CVADs, and 62 patients (40%)
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 42Testicular cancer is highly treatable - Mayo Clinic Comprehensive Cancer Center Blog - 4 month(s) ago
Dr. Bradley Leibovich discusses testicular cancer symptoms and explains that a cure is possible for most people diagnosed with the […]
Source: cancerblog.mayoclinic.orgCategories: General Medicine News, General Journals & SocietTweet
Join this insightful conversation hosted by @zklaassen_md with #TesticularCancer survivors Connor O'Leary & Freeman McClusky as they delve into the mission of @TCancer. Learn about the foundation's dedication to education, awareness, and support > https://t.co/cDiaNuxyV5 https://t.co/Lnyd06lmIg